LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,092
تعداد مقالات10,022
تعداد مشاهده مقاله27,191,193
تعداد دریافت فایل اصل مقاله7,459,202
Asilian, Ali, Iraji, Fariba, Hosseini, Sayed Mohsen, Mohammadian Dehkordi, Parisa. (1402). Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19. سامانه مدیریت نشریات علمی, 49(2), 134-136. doi: 10.30476/ijms.2023.98516.3053
Ali Asilian; Fariba Iraji; Sayed Mohsen Hosseini; Parisa Mohammadian Dehkordi. "Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19". سامانه مدیریت نشریات علمی, 49, 2, 1402, 134-136. doi: 10.30476/ijms.2023.98516.3053
Asilian, Ali, Iraji, Fariba, Hosseini, Sayed Mohsen, Mohammadian Dehkordi, Parisa. (1402). 'Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19', سامانه مدیریت نشریات علمی, 49(2), pp. 134-136. doi: 10.30476/ijms.2023.98516.3053
Asilian, Ali, Iraji, Fariba, Hosseini, Sayed Mohsen, Mohammadian Dehkordi, Parisa. Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19. سامانه مدیریت نشریات علمی, 1402; 49(2): 134-136. doi: 10.30476/ijms.2023.98516.3053

Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19

Iranian Journal of Medical Sciences
مقاله 27، دوره 49، شماره 2، اردیبهشت 2024، صفحه 134-136    اصل مقاله (169.71 K)
نوع مقاله: Letter(s) to the Editor
شناسه دیجیتال (DOI): 10.30476/ijms.2023.98516.3053
نویسندگان
Ali Asilian1، 2؛ Fariba Iraji2؛ Sayed Mohsen Hosseini3؛ Parisa Mohammadian Dehkordi* 4
1Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2Department of Dermatology, Skin and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
4Department of Dermatology Skin Diseases and Leishmaniasis Research Center School of Medicine Isfahan University of Medical Sciences Isfahan Iran
چکیده
Hair loss, which is known as telogen effluvium (TE), was reported in COVID-19 patients both during and after their recovery.

تازه های تحقیق

Ali Asilian (Google Scholar)

Parisa Mohammadian Dehkordi (Google Scholar)

کلیدواژه‌ها
COVID-19؛ Hair loss؛ Hospitalization
سایر فایل های مرتبط با مقاله
مراجع
  1. Hussain N, Agarwala P, Iqbal K, Omar HMS, Jangid G, Patel V, et al. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. J Med Virol. 2022;94:1391-401. doi: 10.1002/jmv.27534. PubMed PMID: 34931698.
  2. Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2022;191:1677-81. doi: 10.1007/s11845-021-02754-5. PubMed PMID: 34467470; PubMed Central PMCID: PMCPMC8407603.
  3. Seyfi S, Alijanpour R, Aryanian Z, Ezoji K, Mahmoudi M. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. J Med Life. 2022;15:631-4. doi: 10.25122/jml-2021-0380. PubMed PMID: 35815081; PubMed Central PMCID: PMCPMC9262270.
  4. Torres F, Tosti A. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. Semin Cutan Med Surg. 2015;34:67-71. doi: 10.12788/j.sder.2015.0142. PubMed PMID: 26176282.
  5. Miola AC, Florencio LC, Bellini Ribeiro ME, Alcantara GP, Muller Ramos P, Miot HA. Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization. J Am Acad Dermatol. 2022;86:e207-e8. doi: 10.1016/j.jaad.2021.09.072. PubMed PMID: 34906662; PubMed Central PMCID: PMCPMC8665661.
آمار
تعداد مشاهده مقاله: 2,954
تعداد دریافت فایل اصل مقاله: 161


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب